The network predicted that quercetin, luteolin, kaempferol, and phaseoloidin might be potential ingredients in GP and that PTGS2, AKT, MAPK1, TNF, INSR, IL6, MAPK8, PRKCB, NOS3, iNS, PIK3CG, BCL2, VEGFA, EGFR, CCND1, CASP3, and FOS might be potential targets of T2DM. The gene discussed is FOS; the disease is type 2 diabetes mellitus.